Birchview Capital as of Dec. 31, 2019
Portfolio Holdings for Birchview Capital
Birchview Capital holds 52 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 36.3 | $50M | 779k | 64.19 | |
| Accelr8 Technology | 26.8 | $37M | 2.2M | 16.90 | |
| Neurocrine Biosciences (NBIX) | 4.3 | $5.9M | 55k | 107.49 | |
| Quidel Corporation | 2.7 | $3.7M | 49k | 75.03 | |
| Oxford Immunotec Global | 2.0 | $2.8M | 170k | 16.60 | |
| Vermillion | 1.9 | $2.6M | 3.2M | 0.81 | |
| Rts/bristol-myers Squibb Compa | 1.5 | $2.1M | 700k | 3.01 | |
| Contrafect | 1.3 | $1.8M | 2.8M | 0.62 | |
| Eqt Midstream Partners | 1.1 | $1.5M | 51k | 29.97 | |
| Karyopharm Therapeutics | 1.1 | $1.5M | 80k | 19.18 | |
| Soleno Therapeutics | 1.1 | $1.5M | 511k | 2.94 | |
| Biogen Idec (BIIB) | 1.1 | $1.5M | 5.0k | 296.80 | |
| Harrow Health (HROW) | 1.0 | $1.4M | 180k | 7.78 | |
| Vanda Pharmaceuticals (VNDA) | 0.9 | $1.3M | 80k | 16.41 | |
| Masimo Corporation (MASI) | 0.9 | $1.3M | 8.0k | 158.00 | |
| Amarin Corporation | 0.9 | $1.3M | 59k | 21.44 | |
| Arvinas Ord (ARVN) | 0.9 | $1.2M | 30k | 41.10 | |
| Albireo Pharma | 0.9 | $1.2M | 48k | 25.42 | |
| Dermira | 0.9 | $1.2M | 80k | 15.16 | |
| G1 Therapeutics | 0.8 | $1.1M | 40k | 26.42 | |
| Intercept Pharmaceuticals In | 0.8 | $1.0M | 8.3k | 123.98 | |
| Arena Pharmaceuticals | 0.7 | $999k | 22k | 45.41 | |
| Chemocentryx | 0.7 | $989k | 25k | 39.56 | |
| Acceleron Pharma | 0.7 | $990k | 19k | 53.02 | |
| ImmunoGen | 0.7 | $920k | 180k | 5.11 | |
| Wright Medical | 0.7 | $914k | 30k | 30.47 | |
| Myriad Genetics (MYGN) | 0.6 | $817k | 30k | 27.23 | |
| Qiagen Nv | 0.5 | $676k | 20k | 33.80 | |
| Odonate Therapeutics Ord | 0.5 | $649k | 20k | 32.45 | |
| Corcept Therapeutics Incorporated (CORT) | 0.4 | $605k | 50k | 12.10 | |
| ACADIA Pharmaceuticals (ACAD) | 0.4 | $599k | 14k | 42.79 | |
| Pioneer Natural Resources | 0.4 | $575k | 3.8k | 151.32 | |
| Biohaven Pharmaceutical Holding | 0.4 | $544k | 10k | 54.40 | |
| Kalvista Pharmaceuticals (KALV) | 0.4 | $534k | 30k | 17.80 | |
| Gossamer Bio (GOSS) | 0.3 | $469k | 30k | 15.63 | |
| United Therapeutics Corporation (UTHR) | 0.3 | $440k | 5.0k | 88.00 | |
| Xencor (XNCR) | 0.3 | $423k | 12k | 34.39 | |
| Voyager Therapeutics (VYGR) | 0.3 | $419k | 30k | 13.97 | |
| Progyny (PGNY) | 0.3 | $412k | 15k | 27.47 | |
| Amicus Therapeutics (FOLD) | 0.3 | $370k | 38k | 9.74 | |
| Sientra | 0.3 | $358k | 40k | 8.95 | |
| Lexicon Pharmaceuticals (LXRX) | 0.2 | $332k | 80k | 4.15 | |
| Veracyte (VCYT) | 0.2 | $301k | 11k | 27.96 | |
| Apellis Pharmaceuticals (APLS) | 0.2 | $245k | 8.0k | 30.62 | |
| Encana Corp | 0.2 | $232k | 50k | 4.68 | |
| Dicerna Pharmaceuticals | 0.2 | $220k | 10k | 22.00 | |
| Continental Resources | 0.1 | $206k | 6.0k | 34.33 | |
| Tg Therapeutics (TGTX) | 0.1 | $167k | 15k | 11.13 | |
| Yield10 Bioscience | 0.1 | $129k | 758k | 0.17 | |
| Workhorse Group Inc ordinary shares | 0.1 | $76k | 25k | 3.04 | |
| Livent Corp | 0.1 | $86k | 10k | 8.60 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $69k | 20k | 3.45 |
